Cargando…
Enzalutamide in patients with non-metastatic castration-resistant prostate cancer after combined androgen blockade for recurrence following radical treatment in Japan (Japanese research for patients with non-metastatic castration-resistant prostate cancer-enzalutamide: JCASTRE-zero)—a prospective single-arm interventional study
BACKGROUND: The effect of enzalutamide in patients with non-metastatic castration-resistant prostate cancer after combined androgen blockade, which represents a patient profile similar to real-world clinical practice in Japan, remains unknown. Therefore, we investigate the efficacy and safety of enz...
Autores principales: | Sugimoto, Mikio, Kato, Takuma, Tohi, Yoichiro, Shimizu, Yosuke, Matsumoto, Ryuji, Inoue, Takahiro, Takezawa, Yutaka, Masui, Kimihiko, Sasaki, Hiroshi, Hirama, Hiromi, Saito, Shiro, Egawa, Shin, Kamoto, Toshiyuki, Teramukai, Satoshi, Kojima, Shinsuke, Kikuchi, Takashi, Kakehi, Yoshiyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9476281/ https://www.ncbi.nlm.nih.gov/pubmed/36104667 http://dx.doi.org/10.1186/s12894-022-01096-3 |
Ejemplares similares
-
Enzalutamide for patients with metastatic castration-resistant prostate cancer
por: Ramadan, Wijdan H, et al.
Publicado: (2015) -
Enzalutamide for the treatment of metastatic castration-resistant prostate cancer
por: Rodriguez-Vida, Alejo, et al.
Publicado: (2015) -
Metastatic Castration-Resistant Prostate Cancer: Critical Review of Enzalutamide
por: El-Amm, Joelle, et al.
Publicado: (2013) -
Erratum for “Metastatic Castration-Resistant Prostate Cancer: Critical Review of Enzalutamide”
por: El-Amm, Joelle, et al.
Publicado: (2013) -
Enzalutamide: targeting the androgen signalling pathway in metastatic castration‐resistant prostate cancer
por: Schalken, Jack, et al.
Publicado: (2015)